The U.S. blood pressure monitoring devices market size was estimated at USD 1.95 billion in 2023 and is expected to be worth around USD 4.66 billion by 2033, poised to grow at a compound annual growth rate (CAGR) of 9.1% during the forecast period 2024 to 2033.
The market's expansion is primarily driven by technological developments in blood pressure monitors, the increased prevalence of hypertension, and the growing geriatric population.
The growing number of older people globally has resulted in a huge increase in the demand for Blood Pressure Monitoring Devices. According to the United Nations, the number of individuals aged 65 and over is expected to treble to 1.5 billion by 2050. Manufacturers have prioritized the development of novel, user-friendly, and cost-effective blood pressure measurement equipment. In the United States, hypertension affects a large number of people, resulting in heart failure and stroke.
According to CDC figures, 119.1 million individuals in the country have hypertension, resulting in a high need for Blood Pressure Monitoring Devices. Manufacturers are constantly developing new technologies, such as digital sphygmomanometers, to meet the market's demands. To address the significant prevalence of hypertension among Americans, the Centers for Medicare & Medicaid Services have expanded reimbursement coverage for Ambulatory Blood Pressure Monitoring Devices (ABPM). Currently, ABPM is covered for patients whose in-office blood pressure measurements surpass 140/90 mm Hg on three distinct occasions. To be eligible for Medicare reimbursement, ABPM must last at least 24 hours.
Report Attribute |
Details |
Market Size in 2024 | USD 2.13 Billion |
Market Size by 2033 | USD 4.66 Billion |
Growth Rate From 2024 to 2033 | CAGR of 9.1% |
Base Year | 2023 |
Forecast Period | 2024 to 2033 |
Segments Covered | Product, end-use |
Market Analysis (Terms Used) | Value (US$ Million/Billion) or (Volume/Units) |
Report Coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Key Companies Profiled | American Diagnostics Corporation; SunTech Medical, Inc ; GE Healthcare, A&D Medical Inc; Kaz Inc.; GF Health Products Inc. Spacelabs Healthcare Inc.; OMRON Healthcare, Inc. Welch Allyn; Briggs Healthcare; Spacelabs Healthcare |
In 2023, aneroid blood pressure monitors dominated the market with a 36.19% share. The multifaceted applications of aneroid blood monitors, including easy accessibility, transport, and usage, are driving the growth of this segment. Another advantage of aneroid blood monitors is that they don't contain mercury, making them lightweight and portable. The higher preference for aneroid blood pressure in hospitals across the US is likely to boost the market growth even further. The digital blood pressure monitors segment is projected to grow at the fastest CAGR of 11.5% from 2024 to 2033. This growth is driven by the increasing awareness of cardiovascular diseases, hypertension, and BP monitoring devices among the US population.
Additionally, the rising use of advanced technology-based Blood Pressure Monitoring Deviceswearables such as apps and mobiles are boosting the growth of this segment. The growth is also fueled by rising R&D activities for manufacturing innovative devices. For example, in January 2023, researchers from the University of California San Diego Jacobs School of Engineering announced the development of a blood pressure monitor that can be connected to a smartphone. This novel monitor is designed to be small, can be operated with one touch, and is more cost-effective than traditional blood monitors.
In the US, hospitals and clinics have been the dominant end-users of blood pressure monitors, accounting for around 65.19% of the market share in 2023. This can be attributed to the rising number of hospitalizations among the US population due to chronic diseases, injuries, and other emergencies. Notably, hospitals and clinics are the major consumers of blood pressure monitors as efficient pressure management is essential in a hospital healthcare setting. According to statistics published by the Centers for Disease Control and Prevention, around 48.1% of adults in the US suffer from hypertension, which further drives the demand for blood pressure monitors in hospitals and clinics.
Additionally, as per an article published by Journal of Managed Care and Specialty Pharmacy, rate of re-hospitalization due to heart failure is between 21-23% among the US population, which further emphasizes the importance of efficient pressure management in hospitals and clinics. On the other hand, the homecare segment is expected to grow at the fastest CAGR of 10.9% from 2024 to 2033.
The growth is primarily driven by the increasing popularity of home monitoring devices due to their user-friendly nature, reliability, cost-effectiveness, and reduced healthcare costs. The integration of technological trends such as WI-FI and cloud has further aided the growth of the market. Moreover, reimbursement or coverage policies provided by the US government have played a significant role in boosting the demand for blood pressure monitors in the homecare segment. As a result, the homecare segment is expected to witness significant growth in the coming years.
Key companies in U.S. Blood Pressure Monitoring Devices market include Allyn, Inc., A&D Medical Inc., SunTech Medical, Inc., American Diagnostics Corporation, GE Healthcare, Kaz Inc., GF Health Products Inc., Spacelabs Healthcare Inc., and
There is intense competition in the U.S. Blood Pressure Monitoring Devices Market. The adoption of competitive strategies such as mergers & acquisitions, strategic alliances, collaborative agreements, and partnerships helps to sustain the competition. The industry growth is directly associated with the rising investments by manufacturers for the development of cost-effective, innovative, and easy-to-use products.
This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Nova one advisor, Inc. has segmented the U.S. Blood Pressure Monitoring Devices market.
By Aneroid Blood Pressure Monitors
By End-user
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on U.S. Blood Pressure Monitoring Devices Market
5.1. COVID-19 Landscape: U.S. Blood Pressure Monitoring Devices Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8.U.S. Blood Pressure Monitoring Devices Market, By Product
8.1. U.S. Blood Pressure Monitoring Devices Market Revenue and Volume, by Product, 2024-2033
8.1.1. Digital Blood Pressure Monitor
8.1.1.1. Market Revenue and Volume Forecast (2021-2033)
8.1.2. Sphygmomanometer
8.1.2.1. Market Revenue and Volume Forecast (2021-2033)
8.1.3. Ambulatory Blood Pressure Monitor
8.1.3.1. Market Revenue and Volume Forecast (2021-2033)
8.1.4. Instruments & Accessories
8.1.4.1. Market Revenue and Volume Forecast (2021-2033)
8.1.5. Transducers
8.1.5.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 9. U.S. Blood Pressure Monitoring Devices Market, By End User
9.1. U.S. Blood Pressure Monitoring Devices Market Revenue and Volume, by End User, 2024-2033
9.1.1. Ambulatory Surgical Centers & Clinics
9.1.1.1. Market Revenue and Volume Forecast (2021-2033)
9.1.2. Hospitals
9.1.2.1. Market Revenue and Volume Forecast (2021-2033)
9.1.3. Home Healthcare
9.1.3.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 10. U.S. Blood Pressure Monitoring Devices Market and Trend Forecast
10.1. U.S.
10.1.1. Market Revenue and Volume Forecast, by Product (2021-2033)
10.1.2. Market Revenue and Volume Forecast, by End User (2021-2033)
Chapter 11. Company Profiles
11.1. Koninklijke Philips N.V.
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. General Electric Company
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. SunTech Medical, Inc.
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Welch Allyn
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. American Diagnostic Corporation
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Briggs Healthcare
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Spacelabs Healthcare
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. GF HEALTH PRODUCTS, INC.
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Rossmax International Limited
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Microlife Corporation
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms